Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07313384 · ClinicalTrials.gov registry record

Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy

A clinical trial of Obesity (Disorder) and Obesity Type 2 Diabetes Mellitus, sponsored by University of South Carolina.

Recruiting
Registry status
50
Enrollment target
2
Study locations

NCT07313384 is a study of Obesity (Disorder) and Obesity Type 2 Diabetes Mellitus that is actively recruiting participants, run by University of South Carolina. The registered enrollment target is 50 participants, below the 104-participant average among 5 other Obesity (Disorder) trials with a reported enrollment target (52% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07313384, a study of Obesity (Disorder) and Obesity Type 2 Diabetes Mellitus, is actively recruiting participants, sponsored by University of South Carolina.

RECRUITING
Registry status
50 participants
Enrollment target
2
Study locations

Study Summary

The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since these medications reduce food intake, it's important to ensure the diet is nutritious even with fewer calories to help with long-term weight control and health. Most research has looked at how the body responds to the medication and whether patients take it as prescribed, but not much is known about what patients actually experience, what they think they need, or how they could use additional support. Understanding patients' views can help create better lasting solutions. Note that this study does not provide free GLP-1 medication.

Conditions Studied

Obesity (Disorder) Obesity Type 2 Diabetes Mellitus

Interventions

  • DRUG GLP-1 Therapy

Study Locations (2)

South Carolina

  • University South Carolina - Columbia
  • Prisma Health Weight Management Institute - Greenville

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-02-11
Est. Completion 2026-12-01

Sponsor

University of South Carolina

157 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07313384

The ClinicalTrials.gov registry entry for NCT07313384 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 104-participant average among 5 other Obesity (Disorder) trials with a reported enrollment target (52% lower). The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity (Disorder) appearing as the primary indexed condition, and to 1 intervention - of which GLP-1 Therapy is the first listed.

NCT07313384 reports 2 study locations spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT07313384 about?

NCT07313384 is a clinical study titled "Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy". The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since the...

What is the current status of trial NCT07313384?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-02-11. Estimated completion is 2026-12-01.

What conditions does trial NCT07313384 study?

This clinical trial studies the following conditions: Obesity (Disorder), Obesity Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT07313384?

The interventions under investigation include: GLP-1 Therapy (DRUG).

Who is sponsoring clinical trial NCT07313384?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07313384 being conducted?

This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity (Disorder)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity (Disorder)

All registered trials for this condition

Obesity Type 2 Diabetes Mellitus

All registered trials for this condition

South Carolina

All trials with a study site in South Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.